AFMD - Affimed N.V. Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Affimed NV (NASDAQ:AFMD) price target lowered to $5.00 by ... Oct 11, 2018 · Today, SunTrust Banks lowered its price target on Affimed NV (NASDAQ:AFMD) to $5.00 per share. There are 3 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
AFMD | Complete Affimed N.V. stock news by MarketWatch. View real-time stock Affimed started at outperform with $8 stock price target at SVB Leerink. Mar. 1 brokerages have issued 12-month price objectives for Affimed's shares. Their forecasts range from $10.00 to $10.00. On average, they expect Affimed's stock Affimed Stock Price Forecast, AFMD stock price prediction. The best long-term & short-term Affimed share price prognosis for 2020, 2021, 2022, 2023, 2024, Analysts expect revenue of $60.3 million.Citing the unknown duration and extent of COVID-19's impact on its business and the health care system in general, the
Affimed N.V. (AFMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Affimed N.V. (AFMD) Real-Time Stock Quote - NASDAQ.com AFMD's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low AFMD Stock Quote - Affimed N.V. Price - Nasdaq Stock quote for Affimed N.V. Common Stock (AFMD) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. AFMD Affimed Therapeutics — Stock Price and Discussion ...
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany.
AFMD Stock Price and Chart — NASDAQ:AFMD — TradingView View live AFFIMED N V chart to track its stock's price action. Find market predictions, AFMD financials and market news. View live AFFIMED N V chart to track its stock's price action. Find market predictions, AFMD financials and market news. TradingView . EN. Affimed NV engages in discovering and developing of targeted cancer AFMD - Affirmed Therapeutics B.V. Summary, Stock Quote and ... Jan 01, 2010 · Affirmed Therapeutics B.V. (NASDAQ: AFMD) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Affimed N.V. [AFMD]: Target Price for AFMD is $6.87 as ... Jan 06, 2020 · Affimed N.V. is said to have a 12-month price target set at $6.87. That means that the stock has a strong potential to acquire 4.32% increase from the current trading price. Affimed N.V. [NASDAQ:AFMD]: Analyst Rating and Earnings. Its stock price has been found in the range of 2.18 to 4.68. This is compared to its latest closing price of $2.65.